Business Context and Reporting Period
This Form 8-K is a current report filed by Black Diamond Therapeutics, Inc. on April 21, 2021. The filing addresses Item 5.08 regarding shareholder director nominations and the scheduling of the company's 2021 Annual Meeting of Stockholders.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and meeting logistics rather than financial performance.
Material Changes
There are no material financial changes reported in this document. The primary event is the establishment of the record date for the 2021 Annual Meeting and the deadlines for shareholder proposals.
Guidance, Outlook, and Corporate Actions
- Annual Meeting Date: June 18, 2021, to be held online at 9:00 a.m. Eastern Time.
- Record Date: April 21, 2021, for determining stockholders entitled to notice and vote.
- Proposal Deadlines: Stockholders wishing to submit proposals under Rule 14a-8 or nominate directors under the By-laws must submit written notice by the close of business on April 23, 2021.
- Reasoning: The company did not hold an annual meeting the previous year, necessitating this specific timeline for the 2021 meeting.
Key Facts for Investor Verification
- Verify the record date of April 21, 2021, to confirm eligibility to vote at the upcoming Annual Meeting.
- Note the April 23, 2021 deadline for submitting shareholder proposals or director nominations.
- Confirm the meeting format is virtual (online) as scheduled for June 18, 2021.
- Review the company's Amended and Restated By-laws for specific requirements regarding director nominations outside of Rule 14a-8.